Skip to main content
SpringerLink
Log in

Overnight Low Dose Dexamethasone Suppression Test—1 mg

  • Chapter
  • First Online:
The Cleveland Clinic Manual of Dynamic Endocrine Testing

  • 1258 Accesses

Abstract

This test is performed to evaluate for Cushing’s syndrome and adrenal incidentaloma for subclinical Cushing’s syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kannan S, Remer EM, Hamrahian AH. Evaluation of patients with adrenal incidentalomas. Curr Opin Endocrinol Diabetes Obes. 2013;20(3):161–9.

    Article  CAS  PubMed  Google Scholar 

  2. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B. Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome—recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997;34(Pt 3):222–9.

    Article  CAS  PubMed  Google Scholar 

  3. Martin NM, Dhillo WS, Meeran K. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. Clin Endocrinol (Oxf). 2007;67(3):476.

    Article  CAS  Google Scholar 

  4. Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007;92(4):1326–33.

    Article  CAS  PubMed  Google Scholar 

  5. Kyriazopoulou V, Vagenakis AG. Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy. J Clin Endocrinol Metab. 1992;75(1):315–7.

    CAS  PubMed  Google Scholar 

  6. Meikle AW. Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol (Oxf). 1982;16(4):401–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Diabetes and Metabolism, Cleveland Clinic, Cleveland, Ohio, USA

    Ahmet Bahadir Ergin, Amir H. Hamrahian & A. Laurence Kennedy

  2. Department of Clinical Pathology, Cleveland Clinic, Cleveland, Ohio, USA

    Manjula K. Gupta

Authors
  1. Ahmet Bahadir Ergin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amir H. Hamrahian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Laurence Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manjula K. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmet Bahadir Ergin .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ergin, A., Hamrahian, A., Kennedy, A., Gupta, M. (2015). Overnight Low Dose Dexamethasone Suppression Test—1 mg. In: The Cleveland Clinic Manual of Dynamic Endocrine Testing. Springer, Cham. https://doi.org/10.1007/978-3-319-13048-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13048-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13047-7

  • Online ISBN: 978-3-319-13048-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation